CRO Clinigen is teaming up with biotech Tesaro and its PARP ovarian cancer med niraparib to help launch an early access program in Europe, coming after the…

Activist investor Starboard Value is demonstrating its confidence in Parexel by disclosing a 5.7% stake buy in the company, immediately after news of the CRO’s…

PPD has put its medical affairs research operations team under Evidera, the evidence-based solutions subsidiary PPD bought last year.

WIRB-Copernicus Group continued an acquisition spree with purchases of electronic clinical outcome assessments specialists MedAvante and ProPhase.

Not a week seems to go by without a CRO sale rumor, and now the Wall Street Journal is adding Parexel to that list.

Clinical trial supporting platform MyClin just launched Clinical Works, a set of services that designs highly engaging materials to streamline trials.

Asia-Pacific CRO George Clinical has topped up its cancer services and boosted its U.S. presence after acquiring Memphis, Tennessee-based Vector Oncology'…

LabCorp is planning a rejig of its CRO business Covance, and the short-term plan includes letting go of a lab along with the employees stationed there.

Outset Medical raised $76.5 million in its Series C round, which will go toward scaling up the commercial launch of its all-in-one dialysis device.